Stay updated on Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3. The HHS Vulnerability Disclosure and Revision: v3.3.2 references have been removed.
    Difference
    0.1%
    Check dated 2025-12-23T20:50:41.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.2 on the page.
    Difference
    0.1%
    Check dated 2025-11-25T11:48:20.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Removed a government funding operating status notice. The study details and contacts on the page remain unchanged; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:14:06.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The new screenshot shows layout and styling changes without changes to the trial's core details such as eligibility, locations, or enrollment.
    Difference
    0.4%
    Check dated 2025-11-03T21:13:38.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Major update: operating-status notice and new version v3.2.0; old v3.1.0 reference removed.
    Difference
    5%
    Check dated 2025-10-06T05:52:07.000Z thumbnail image
  9. Check
    102 days ago
    Change Detected
    Summary
    Page now shows revision to v3.1.0 and removes several drug-safety-related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a shift away from those topics while adding a new version.
    Difference
    0.6%
    Check dated 2025-09-29T03:11:07.000Z thumbnail image

Stay in the know with updates to Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page.